<DOC>
	<DOC>NCT02243319</DOC>
	<brief_summary>The purpose of this study is to investigate the pharmacokinetic drug interactions between HGP1201 and HGP0904</brief_summary>
	<brief_title>Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904</brief_title>
	<detailed_description>Randomized, open-label, multiple dose , 3-treatment, 6-sequence, 3-period, crossover study, The purpose of this study is to investigate the pharmacokinetic drug interactions between HGP1201 and HGP0904</detailed_description>
	<criteria>Healthy male volunteer, age 19~45 years The result of Body Mass Index(BMI) is not less than 19 kg/m2 , no more than 28 kg/m2 Subject who has the ability to comprehend the study objectives, contents and the property of the study drug before participating in the trial. Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study History of relevant drug allergies or clinically significant hypersensitivity reaction.</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>